Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 9:31 AM ET

Date/Time Source News Release
05/13/2025 07:30 AM EDT Newsfile Adaptimmune Reports Q1 Financial Results and Provides Business Update
05/07/2025 12:00 PM EDT Newsfile Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025
03/20/2025 07:00 AM EDT Newsfile Adaptimmune Provides Q4 and Full Year 2024 Business Update
03/12/2025 04:54 PM EDT Newsfile Adaptimmune to Report Full Year and Q4 2024 Financial and Business Updates on Thursday, March 20, 2025
01/30/2025 04:00 PM EST Newsfile Adaptimmune to Participate in the Guggenheim Securities SMID Cap Biotech Conference February 6, 2025
01/13/2025 08:00 AM EST Newsfile Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
12/19/2024 07:30 AM EST Newsfile Adaptimmune Announces Changes to its Executive Leadership Team Based in The UK
12/02/2024 04:00 PM EST Newsfile First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel)
11/13/2024 04:05 PM EST Newsfile Adaptimmune Reports Q3 2024 Financial and Business Updates
11/13/2024 09:00 AM EST Newsfile Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial
Page

Additional News

As of June 3, 2025 • 9:31 AM ET

Date/Time Source News Release
05/30/2025 03:00 PM EDT SeekingAlpha SA Asks: Which oncology companies are attractive M&A targets?
05/22/2025 12:34 PM EDT SeekingAlpha Prices of new U.S. drugs doubled over the past four years: report
05/13/2025 02:00 PM EDT SeekingAlpha Adaptimmune targets $35M-$45M TECELRA sales in 2025 as ATC network nears completion
05/13/2025 01:59 PM EDT SeekingAlpha Adaptimmune Therapeutics plc (ADAP) Q1 2025 Earnings Call Transcript
05/13/2025 07:34 AM EDT SeekingAlpha Adaptimmune GAAP EPS of -$0.03 beats by $0.11, revenue of $7.29M beats by $0.74M
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Adaptimmune Therapeutics plc
05/12/2025 06:48 PM EDT KlickAnalytics ADAP - Historical Price Movements Surrounding Earnings
05/12/2025 06:43 PM EDT KlickAnalytics ADAP - Historical Earnings Price Analysis
05/12/2025 12:06 PM EDT SeekingAlpha Adaptimmune Q1 2025 Earnings Preview
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.